Cephalon's Provigil Patent Is Enforceable, Fed. Circ. Told
Cephalon Inc. urged a Federal Circuit panel on Wednesday to reverse a lower court's ruling that its patent for narcolepsy drug Provigil is unenforceable due to inequitable conduct, claiming Apotex Inc....To view the full article, register now.
Already a subscriber? Click here to view full article